Back to today’s briefing

Story perspectives

Weight Loss Drug GLP-1 May Curb Alcohol Intake

10/31/2025

44 8

Summary

Story summary

A study from Virginia Tech's Fralin Biomedical Research Institute finds that GLP-1 agonists, used for weight loss, may reduce alcohol consumption.
The drugs slow alcohol absorption into the bloodstream, leading to less intoxication.
In a pilot study, GLP-1 users showed an average reduction of 68% in alcohol intake.
Researchers say further studies are needed to confirm the findings and evaluate GLP-1s as a therapy for reducing alcohol use.

1 of 1

Story summary

A study from Virginia Tech's Fralin Biomedical Research Institute finds that GLP-1 agonists, used for weight loss, may reduce alcohol consumption.
The drugs slow alcohol absorption into the bloodstream, leading to less intoxication.
In a pilot study, GLP-1 users showed an average reduction of 68% in alcohol intake.
Researchers say further studies are needed to confirm the findings and evaluate GLP-1s as a therapy for reducing alcohol use.